{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:01Z","timestamp":1788307741151,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971980"],"award-info":[{"award-number":["81971980"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cca.2020.04.002","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T11:01:06Z","timestamp":1586170866000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Research status and perspectives for pathogenic spirochete vaccines"],"prefix":"10.1016","volume":"507","author":[{"given":"Junxia","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9542-6896","authenticated-orcid":false,"given":"Feijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cca.2020.04.002_b0005","doi-asserted-by":"crossref","first-page":"e3898","DOI":"10.1371\/journal.pntd.0003898","article-title":"Global morbidity and mortality of leptospirosis: a systematic review","volume":"9","author":"Costa","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"9","key":"10.1016\/j.cca.2020.04.002_b0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/vbz.2017.2127","article-title":"Brave new worlds: the expanding universe of lyme disease","volume":"17","author":"Stone","year":"2017","journal-title":"Vector-Borne Zoonot. Dis."},{"issue":"10078","key":"10.1016\/j.cca.2020.04.002_b0015","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(16)32411-4","article-title":"Syphilis","volume":"389","author":"Hook","year":"2017","journal-title":"The Lancet"},{"issue":"suppl_3","key":"10.1016\/j.cca.2020.04.002_b0020","doi-asserted-by":"crossref","first-page":"s253","DOI":"10.1093\/cid\/ciq116","article-title":"Vaccines against Lyme disease: what happened and what lessons can we learn?","volume":"52","author":"Poland","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.cca.2020.04.002_b0025","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/21645515.2017.1405884","article-title":"Human leptospirosis vaccines in China","volume":"14","author":"Xu","year":"2017","journal-title":"Hum. Vacc. Immunotherapeut."},{"issue":"5","key":"10.1016\/j.cca.2020.04.002_b0030","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/QCO.0000000000000097","article-title":"Leptospira and leptospirosis in China","volume":"27","author":"Hu","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.cca.2020.04.002_b0045","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.110.5.1206","article-title":"Immunity in experimental syphilis. VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by -irradiation","volume":"110","author":"Miller","year":"1973","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cca.2020.04.002_b0050","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/infdis\/jiq127","article-title":"Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant","volume":"203","author":"Srikram","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cca.2020.04.002_b0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetmic.2018.07.018","article-title":"Heterologous protection elicited by a live, attenuated, Leptospira vaccine","volume":"223","author":"Murray","year":"2018","journal-title":"Vet. Microbiol."},{"issue":"2","key":"10.1016\/j.cca.2020.04.002_b0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/JB.01109-06","article-title":"Borrelia burgdorferi alters its gene expression and antigenic profile in response to CO2 levels","volume":"189","author":"Hyde","year":"2007","journal-title":"J. Bacteriol."},{"issue":"7","key":"10.1016\/j.cca.2020.04.002_b0065","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/JCM.37.7.2137-2141.1999","article-title":"Borrelia burgdorferi in tick cell culture modulates expression of outer surface proteins A and C in response to temperature","volume":"37","author":"Obonyo","year":"1999","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0070","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/JCM.38.1.382-388.2000","article-title":"Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice","volume":"38","author":"Schwan","year":"2000","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.cca.2020.04.002_b0075","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/IAI.67.7.3181-3187.1999","article-title":"Effects of environmental pH on membrane proteins in Borrelia burgdorferi","volume":"67","author":"Carroll","year":"1999","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.cca.2020.04.002_b0080","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/CVI.00193-15","article-title":"Vaccination with the OspA - and OspB- negative Borrelia burgdorferi strain 50772 provides significant protection against canine Lyme disease","volume":"22","author":"Lafleur","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"issue":"3","key":"10.1016\/j.cca.2020.04.002_b0085","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1128\/mBio.01153-18","article-title":"Long-term in vitro culture of the syphilis Spirochete Treponema pallidum subsp.pallidum","volume":"9","author":"Edmondson","year":"2018","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.cca.2020.04.002_b0090","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1590\/0074-02760160214","article-title":"Immune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier molecules","volume":"111","author":"Oliveira","year":"2016","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"issue":"13","key":"10.1016\/j.cca.2020.04.002_b0095","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.vaccine.2019.02.010","article-title":"Evaluation of different strategies to promote a protective immune response against leptospirosis using a recombinant LigA and LigB chimera","volume":"37","author":"Da Cunha","year":"2019","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.cca.2020.04.002_b0100","doi-asserted-by":"crossref","first-page":"e180004","DOI":"10.1371\/journal.pone.0180004","article-title":"Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis","volume":"12","author":"Evangelista","year":"2017","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.cca.2020.04.002_b0110","first-page":"779","article-title":"Comparison of Immunoprotection of Leptospira Recombinant Proteins with conventional vaccine in experimental animals","volume":"53","author":"Parthiban","year":"2015","journal-title":"Indian J. Exp. Biol."},{"issue":"5","key":"10.1016\/j.cca.2020.04.002_b0115","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.imbio.2016.01.001","article-title":"Plasmin cleaves fibrinogen and the human complement proteins C3b and C5 in the presence of Leptospira interrogans proteins: A new role of LigA and LigB in invasion and complement immune evasion","volume":"221","author":"Castiblanco-Valencia","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.cca.2020.04.002_b0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2180-11-129","article-title":"Heterologous expression of pathogen-specific genes ligA and ligB in the saprophyte Leptospira biflexa confers enhanced adhesion to cultured cells and fibronectin","volume":"11","author":"Figueira","year":"2011","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.cca.2020.04.002_b0125","unstructured":"Leptospira immunoglobulin-like protein B interacts with the 20th exon of human tropoelastin contributing to leptospiral adhesion to human lung cells."},{"issue":"6","key":"10.1016\/j.cca.2020.04.002_b0130","doi-asserted-by":"crossref","first-page":"e11301","DOI":"10.1371\/journal.pone.0011301","article-title":"The terminal immunoglobulin-like repeats of LigA and LigB of Leptospira enhance their binding to gelatin binding domain of fibronectin and host cells","volume":"5","author":"Lin","year":"2010","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.cca.2020.04.002_b0135","doi-asserted-by":"crossref","first-page":"e4192","DOI":"10.1371\/journal.pntd.0004192","article-title":"Fine Mapping of the Interaction between C4b-Binding Protein and Outer Membrane Proteins LigA and LigB of Pathogenic Leptospira interrogans","volume":"9","author":"Breda","year":"2015","journal-title":"PLoS Negl.Trop. Dis."},{"issue":"11\u201312","key":"10.1016\/j.cca.2020.04.002_b0140","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.vaccine.2003.10.007","article-title":"Leptospiral immunoglobulin-like proteins elicit protective immunity","volume":"22","author":"Koizumi","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.cca.2020.04.002_b0145","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/IAI.01533-13","article-title":"Oral immunization with Escherichia coli expressing a lipidated form of LigA protects hamsters against challenge with leptospira interrogans serovar copenhageni","volume":"82","author":"Lourdault","year":"2014","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.cca.2020.04.002_b0155","doi-asserted-by":"crossref","first-page":"e1422","DOI":"10.1371\/journal.pntd.0001422","article-title":"A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans","volume":"5","author":"Coutinho","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"8","key":"10.1016\/j.cca.2020.04.002_b0160","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1002\/ece3.3961","article-title":"Effects of a zoonotic pathogen, Borrelia burgdorferi, on the behavior of a key reservoir host","volume":"8","author":"Ostfeld","year":"2018","journal-title":"Ecol. Evol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0165","article-title":"Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters","volume":"14","author":"Grosenbaugh","year":"2018","journal-title":"BMC Veterin. Res."},{"issue":"3","key":"10.1016\/j.cca.2020.04.002_b0170","doi-asserted-by":"crossref","first-page":"e151850","DOI":"10.1371\/journal.pone.0151850","article-title":"Oral immunization with OspC does not prevent tick-borne Borrelia burgdorferi infection","volume":"11","author":"Melo","year":"2016","journal-title":"PLoS ONE"},{"issue":"48","key":"10.1016\/j.cca.2020.04.002_b0175","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.1016\/j.vaccine.2011.09.035","article-title":"Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine","volume":"29","author":"Kumar","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.cca.2020.04.002_b0180","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1128\/CVI.00758-12","article-title":"Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for Lyme disease","volume":"20","author":"Floden","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"issue":"3","key":"10.1016\/j.cca.2020.04.002_b0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3409\/fb63_3.159","article-title":"Why is there still no human vaccine against Lyme borreliosis?","volume":"63","author":"Skotarczak","year":"2015","journal-title":"Folia Biol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/000992280204100107","article-title":"Parental knowledge of and attitudes toward LYMErix (Recombinant Osp A Lyme Vaccine)","volume":"41","author":"Barone","year":"2016","journal-title":"Clin. Pediatr."},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: a cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol. Infect."},{"issue":"5","key":"10.1016\/j.cca.2020.04.002_b0200","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1128\/IAI.01424-07","article-title":"A novel Treponema pallidum antigen, TP0136, is an outer membrane protein that binds human fibronectin","volume":"76","author":"Brinkman","year":"2008","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0205","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1038\/ncomms14273","article-title":"A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum","volume":"8","author":"Lithgow","year":"2017","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.cca.2020.04.002_b0210","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.vaccine.2019.02.022","article-title":"Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates","volume":"37","author":"Parveen","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cca.2020.04.002_b0215","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00323-19","article-title":"Evaluation of the protective ability of the Treponema pallidum subspecies pallidum Tp0126 OmpW homolog in the rabbit model of syphilis","author":"Haynes","year":"2019","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.cca.2020.04.002_b0220","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1128\/IAI.00827-06","article-title":"Antigenic variation of TprK V regions abrogates specific antibody binding in syphilis","volume":"74","author":"Lafond","year":"2006","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.cca.2020.04.002_b0225","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1084\/jem.193.9.1015","article-title":"The Tprk protein of Treponema pallidum is periplasmic and is not a target of opsonic antibody or protective immunity","volume":"193","author":"Hazlett","year":"2001","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cca.2020.04.002_b0245","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vaccine.2007.10.029","article-title":"Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters","volume":"26","author":"Faisal","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/infdis\/175.1.91","article-title":"An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi","volume":"175","author":"Luke","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.cca.2020.04.002_b0255","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1286-4579(03)00182-5","article-title":"A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses","volume":"5","author":"Scheiblhofer","year":"2003","journal-title":"Microbes Infect."},{"issue":"10","key":"10.1016\/j.cca.2020.04.002_b0260","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.4161\/hv.7.10.16541","article-title":"Enhanced immune response and protective efficacy of aTreponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2","volume":"7","author":"Zhao","year":"2014","journal-title":"Hum.Vacc."},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0265","first-page":"1","article-title":"Immunogenicity and protective efficacy against Treponema pallidum in New Zealand rabbits immunized with plasmid DNA encoding flagellin","volume":"7","author":"Zheng","year":"2018","journal-title":"Emerging Microbes Infect."},{"issue":"5","key":"10.1016\/j.cca.2020.04.002_b0270","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/1389557516666160801103303","article-title":"Vaccine ingredients: components that influence vaccine efficacy","volume":"17","author":"Kocourkova","year":"2017","journal-title":"Mini-Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0275","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1154-7","article-title":"Cancer DNA vaccines: current preclinical and clinical developments and future perspectives","volume":"38","author":"Lopes","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12866-016-0852-y","article-title":"Chimeric epitope vaccine against Leptospira interrogans infection and induced specific immunity in guinea pigs","volume":"16","author":"Lin","year":"2016","journal-title":"BMC Microbiol."},{"issue":"5","key":"10.1016\/j.cca.2020.04.002_b0285","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CVI.00034-13","article-title":"A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis","volume":"20","author":"Hartwig","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"issue":"11","key":"10.1016\/j.cca.2020.04.002_b0290","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.4161\/hv.7.11.17944","article-title":"Recombinant vaccines against Leptospirosis","volume":"7","author":"Dellagostin","year":"2014","journal-title":"Hum. Vacc."},{"issue":"3","key":"10.1016\/j.cca.2020.04.002_b0295","doi-asserted-by":"crossref","first-page":"e5441","DOI":"10.1371\/journal.pntd.0005441","article-title":"LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis","volume":"11","author":"Conrad","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.cca.2020.04.002_b0300","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.vaccine.2018.12.050","article-title":"Recombinant BCG strains expressing chimeric proteins derived from Leptospira protect hamsters against leptospirosis","volume":"37","author":"Oliveira","year":"2019","journal-title":"Vaccine"},{"issue":"157","key":"10.1016\/j.cca.2020.04.002_b0305","first-page":"5496","article-title":"Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice","volume":"12","author":"Linda","year":"1996","journal-title":"J. Immunol."},{"issue":"24","key":"10.1016\/j.cca.2020.04.002_b0310","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.vaccine.2017.04.079","article-title":"Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development","volume":"35","author":"Izac","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.cca.2020.04.002_b0315","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jmb.2005.04.066","article-title":"Structure-based Design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA","volume":"350","author":"Koide","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cca.2020.04.002_b0320","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.vetmic.2017.05.012","article-title":"Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge","volume":"205","author":"Lalsiamthara","year":"2017","journal-title":"Vet. Microbiol."},{"issue":"3","key":"10.1016\/j.cca.2020.04.002_b0325","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4142\/jvs.2018.19.3.416","article-title":"Effect of immunization routes and protective efficacy of Brucella antigens delivered via Salmonella vector vaccine","volume":"19","author":"Lalsiamthara","year":"2018","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.cca.2020.04.002_b0330","first-page":"1","article-title":"History of leptospirosis and leptospira","volume":"387","author":"Adler","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.cca.2020.04.002_b0335","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1099\/00222615-29-2-115","article-title":"Experimental immunisation of hamsters with lipopolysaccharide antigens of Leptospira interrogans","volume":"29","author":"Jost","year":"1989","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0340","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/ijmr.IJMR_1022_16","article-title":"Advances & challenges in leptospiral vaccine development","volume":"147","author":"Bashiru","year":"2018","journal-title":"Indian J. Med. Res."},{"issue":"5","key":"10.1016\/j.cca.2020.04.002_b0350","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CVI.05720-11","article-title":"Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin","volume":"19","author":"Grassmann","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0355","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1590\/0074-02760140276","article-title":"The use of halloysite clay and carboxyl-functionalised multi-walled carbon nanotubes for recombinant LipL32 antigen delivery enhanced the IgG response","volume":"110","author":"Hartwig","year":"2015","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"issue":"42","key":"10.1016\/j.cca.2020.04.002_b0360","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1016\/j.vaccine.2012.07.053","article-title":"Oral vaccination with vaccinia virus expressing the tick antigen subolesin inhibits tick feeding and transmission of Borrelia burgdorferi","volume":"30","author":"Bensaci","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0365","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1038\/s41598-018-24674-8","article-title":"Heterologous DNA prime-protein boost immunization with RecA and FliD offers cross-clade protection against leptospiral infection","volume":"8","author":"Raja","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cca.2020.04.002_b0370","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CVI.00415-07","article-title":"Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease","volume":"15","author":"Kraiczy","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cca.2020.04.002_b0375","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fimmu.2018.00181","article-title":"Eliminating factor H-binding activity of Borrelia burgdorferi CspZ combined with virus-like particle conjugation enhances its efficacy as a Lyme disease Vaccine","volume":"9","author":"Marcinkiewicz","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2020.04.002_b0380","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.micpath.2018.08.028","article-title":"Antigenic potential of a recombinant polyvalent DNA vaccine against pathogenic leptospiral infection","volume":"124","author":"Garba","year":"2018","journal-title":"Microb. Pathog."},{"issue":"4","key":"10.1016\/j.cca.2020.04.002_b0385","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4014\/jmb.1408.08007","article-title":"Immunogenicity of a DNA and recombinant protein vaccine combining LipL32 and Loa22 for leptospirosis using chitosan as a delivery system","volume":"25","author":"Umthong","year":"2015","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.cca.2020.04.002_b0390","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2017.01.032","article-title":"Immune response and protective profile elicited by a multi-epitope chimeric protein derived from Leptospira interrogans","volume":"57","author":"Fernandes","year":"2017","journal-title":"Int. J. Infect. Dis."},{"issue":"38","key":"10.1016\/j.cca.2020.04.002_b0395","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1016\/j.vaccine.2016.07.059","article-title":"Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release","volume":"34","author":"Kern","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0400","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12917-018-1625-7","article-title":"Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters","volume":"14","author":"Grosenbaugh","year":"2018","journal-title":"BMC Veterin. Res."},{"issue":"11","key":"10.1016\/j.cca.2020.04.002_b0405","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/infdis\/jiw013","article-title":"A Borrelia burgdorferi surface-exposed transmembrane protein lacking detectable immune responses supports pathogen persistence and constitutes a vaccine target","volume":"213","author":"Kung","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"40","key":"10.1016\/j.cca.2020.04.002_b0415","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1016\/j.vaccine.2017.08.054","article-title":"Immunization of mice with Borrelia burgdorferi lp54 gene encoded recombinant proteins does not provide protection against tick transmitted infectious challenge","volume":"35","author":"Brandt","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.cca.2020.04.002_b0420","doi-asserted-by":"crossref","first-page":"e128868","DOI":"10.1371\/journal.pone.0128868","article-title":"Evaluation of Borrelia burgdorferi BbHtrA protease as a vaccine candidate for Lyme Borreliosis in mice","volume":"10","author":"Ullmann","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.cca.2020.04.002_b0425","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11427-012-4434-4","article-title":"Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits","volume":"56","author":"Zhao","year":"2013","journal-title":"Sci. China Life Sci."},{"issue":"12","key":"10.1016\/j.cca.2020.04.002_b0430","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/gt.2014.87","article-title":"Hovius JW. Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection","volume":"21","author":"Wagemakers","year":"2014","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.cca.2020.04.002_b0435","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41541-019-0148-y","article-title":"Identification of antigens presented by MHC for vaccines against tuberculosis","volume":"3","author":"Bettencourt","year":"2020","journal-title":"NPJ Vacc."},{"issue":"5","key":"10.1016\/j.cca.2020.04.002_b0440","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.ttbdis.2018.04.001","article-title":"Controlling ticks and tick-borne diseases\u2026looking forward","volume":"9","author":"de la Fuente","year":"2018","journal-title":"Ticks Tick Borne Dis."},{"issue":"13","key":"10.1016\/j.cca.2020.04.002_b0445","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.vaccine.2019.02.022","article-title":"Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates","volume":"37","author":"Parveen","year":"2019","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.cca.2020.04.002_b0035","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1128\/iai.62.7.2825-2833.1994","article-title":"Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi","volume":"62","author":"Lim","year":"1994","journal-title":"Infect. Immun."},{"issue":"suppl_3","key":"10.1016\/j.cca.2020.04.002_b0040","doi-asserted-by":"crossref","first-page":"s259","DOI":"10.1093\/cid\/ciq117","article-title":"Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis","volume":"52","author":"Steere","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3855\/jidc.9545","article-title":"Protective immunity of recombinant LipL21 and I-LipL21 against Leptospira interrogans serovar Autumnalis N2 infection","volume":"12","author":"Kumari","year":"2018","journal-title":"J. Infect. Dev. Ctries"},{"issue":"33","key":"10.1016\/j.cca.2020.04.002_b0150","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1016\/j.vaccine.2007.05.053","article-title":"The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis","volume":"25","author":"Silva","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.cca.2020.04.002_b0230","first-page":"310","article-title":"The cross-talk between spirochetal lipoproteins and immunity","volume":"5","author":"Kelesidis","year":"2014","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cca.2020.04.002_b0235","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1099\/00221287-146-7-1491","article-title":"Spirochaetal lipoproteins and pathogenesis","volume":"146","author":"Haake","year":"2000","journal-title":"Microbiology"},{"key":"10.1016\/j.cca.2020.04.002_b0240","first-page":"239","article-title":"Spirochetal lipoproteins in pathogenesis and immunity","volume":"415","author":"Haake","year":"2018","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"6","key":"10.1016\/j.cca.2020.04.002_b0345","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1586\/14760584.2015.1026808","article-title":"Biosynthetically engineered lipopolysaccharide as vaccine adjuvant","volume":"14","author":"Zariri","year":"2015","journal-title":"Expert Rev. Vacc"},{"issue":"1","key":"10.1016\/j.cca.2020.04.002_b0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2015.54","article-title":"Borrelia burgdorferi elongation factor EF-Tu is an immunogenic protein during Lyme borreliosis","volume":"4","author":"Carrasco","year":"2019","journal-title":"Emerg. Microbes Infect."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120301480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120301480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:03:27Z","timestamp":1762113807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120301480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":89,"alternative-id":["S0009898120301480"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.04.002","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research status and perspectives for pathogenic spirochete vaccines","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}